Processa Pharmaceuticals Inc. (PCSA) Misses Q3 EPS by 1c

Processa Pharmaceuticals Inc. (NASDAQ: PCSA) reported Q3 EPS of ($0.19), $0.01 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Processa Pharmaceuticals Inc. (PCSA) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• MP Materials seen largely insulated after China export-control move
• NVE Corporation names new CEO and expands board to seven members